top of page
Publications
pub.jpg

Simple, fast, and reliable analysis of label-free proteomics data with the Proteomics Eye (ProtE)

​

Theodoros Margelos, Manousos Makridakis, Charis Gonidaki, Foteini Paradeisi, Manos Vossos, Jerome Zoidakis, Antonia Vlahou, Rafael Stroggilos

​

Read more

image.png

Urinary collagen peptides predict mortality

​

Maria Frantzi, Felix Keller, Agnieszka Latosinska, Joachim Beige, Alexandre Mebazaa, Anaïs Caillard, Dewei An, Paul Perco, Joost P. Schanstra, Lorenzo Catanese, Ralph Wendt, Harald Rupprecht, Jan A. Staessen, Antonia Vlahou, Harald Mischak, Justyna Siwy

​

Read more

image.png

cSTAR analysis identifies endothelial cell cycle as a key regulator of flow-dependent artery remodeling

​

Hanqiang Deng, Oleksii S. Rukhlenko, Divyesh Joshi, Xiaoyue Hu, Philipp Junk, Anna Tuliakova, Boris N. Kholodenko  and Martin A. Schwartz 

​

Read more

image.png

Genomic scarring score predicts the response to PARP inhibitors in non-small cell lung cancer

​

Katerina Tsilingiri, Anna Chalari, Georgia Christopoulou, Alexandra Voutsina, Pantelis Constantoulakis, Κonstantinos Potaris, Ioannis Vamvakaris, Dora Hatzidaki, Georgina Zachou, Giannis Vatsellas, Vassilis Georgoulias, Athanasios Kotsakis & Apostolos Klinakis

​

Read more

image.png

A synthetic data generation pipeline to reproducibly mirror high-resolution multi-variable peptidomics and real-patient clinical data

​

Mayra Alejandra Jaimes Campos, Stipe Kabić, Agnieszka Latosinska, Ena Anicic, Justyna Siwy, Vinko Dragušica, Harald Rupprecht, Lorenzo Catanese, Felix Keller, Paul Perco, Enrique Gomez- Gomez, Joachim Beige, Antonia Vlahou, Harald Mischak, Davorin Vukelić, Tomislav Križan, Maria Frantzi

​

Read more

image.png

Cell State Transition Models Stratify Breast Cancer Cell Phenotypes and Reveal New Therapeutic Targets

​

Oleksii S. Rukhlenko, Hiroaki Imoto, Ayush Tambde, Amy McGillycuddy, Philipp Junk, Anna Tuliakova, Walter Kolch, and Boris N. Kholodenko 

​

Read more

image.png

Cell-specific models reveal conformation-specific RAF inhibitor combinations that synergistically inhibit ERK signaling in pancreatic cancer cells

​

Thomas Sevrin, Hiroaki Imoto, Sarah Robertson, Nora Rauch, Uscinnia Dyn’ko, Katerina Koubova, Kieran Wynne, Walter Kolch, Oleksii S. Rukhlenko, Boris N. Kholodenko

​

Read more

  • Instagram
  • LinkedIn
  • X

MULTIR EU Project

Coordinator address:

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

RUE DE TOLBIAC 101, PARIS 75654, France

Lise BOUSSEMART

Professeur des Universités - Praticien Hospitalier

Coordinator

lise.boussemart@chu-nantes.fr

Join our mailing list! Don’t miss out!

Thanks for subscribing!

Javier Saenz, PhD

javier.saenz@univ-nantes.fr

eu_funded_en.jpg

Thomas Roret 

Project Manager

thomas.roret@univ-nantes.fr

Funded by the European Union. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.

© 2024-2025

bottom of page